股票 › HALO
哈洛泽生物 HALO
美股市值排名 #1314
$103.63 −$19.33 (-15.72%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $103.75 +0.12%
开盘$117.03
昨收$122.96
当日区间$102.52 – $118.26
成交量6.16M
市值$11.81B
市盈率（TTM）25.9
股息率–
财报
财报日平均波动±7.4%近16次财报
收涨次数13 / 1681% 的概率
最佳反应+20.2%
最差反应-9.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | ±5.9% | +20.24% | 超出定价预期 |
| 2026/Q1 | 11 May 2026 | After Market | ±4.6% | +6.81% | 超出定价预期 |
| 2025/Q4 | 17 Feb 2026 | After Market | ±3.4% | -9.01% | 超出定价预期 |
| 2025/Q3 | 3 Nov 2025 | After Market | ±8.5% | +2.79% | 符合区间 |
| 2025/Q2 | 5 Aug 2025 | After Market | ±10.4% | +2.48% | 符合区间 |
| 2025/Q1 | 6 May 2025 | After Market | ±9.5% | +18.12% | 超出定价预期 |
| 2024/Q4 | 18 Feb 2025 | After Market | ±7.7% | -0.22% | 符合区间 |
| 2024/Q3 | 31 Oct 2024 | After Market | ±10.1% | +13.01% | 超出定价预期 |
| 2024/Q2 | 6 Aug 2024 | After Market | ±9.6% | +4.20% | 符合区间 |
| 2024/Q1 | 7 May 2024 | After Market | ±10.6% | +1.94% | 符合区间 |
| 2023/Q4 | 20 Feb 2024 | After Market | ±12.4% | +6.56% | 符合区间 |
| 2023/Q3 | 6 Nov 2023 | After Market | ±9.7% | +10.04% | 超出定价预期 |
| 2023/Q2 | 8 Aug 2023 | After Market | ±9.1% | -1.57% | 符合区间 |
| 2023/Q1 | 9 May 2023 | After Market | ±12.0% | +12.79% | 超出定价预期 |
| 2022/Q4 | 21 Feb 2023 | After Market | ±11.5% | +0.85% | 符合区间 |
| 2022/Q3 | 8 Nov 2022 | After Market | ±8.2% | +8.47% | 超出定价预期 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q3, ended Sep 2026
营收$492.97M+39.2% YoY
营业利润$294.97M+35.4% YoY
净利润$247.05M+41.0% YoY
摊薄每股收益$2.01+40.6% YoY
自由现金流$255.22M+45.4% YoY
经营现金流$258.27M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率82.3%
营业利润率55.9%
净利率26.9%
净资产收益率216.4%
资产收益率17.0%
投入资本回报率19.3%
流动比率3.88
负债/资产比率101.6%
现金及投资$1.07B
总负债$3.25B
净现金（净负债）-$2.18B
自由现金流/营收33.2%
暂无评论——快来第一个聊聊 HALO。
登录后参与讨论。